Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals strong growth in Dairy RNG and India Biodiesel sales, with optimistic guidance for the India biodiesel operations. Despite a negative EBITDA due to seasonality, the company is making significant capital investments. The Q&A highlights potential high revenue from the RD and SAF project and positive market trends for LCFS prices. Financing challenges remain, but the overall sentiment is positive, with expectations of improved margins and strategic expansions. The absence of market cap data limits precise prediction, but the overall sentiment suggests a positive stock price movement.
Revenue $54.6 million in Q1 2026, a 27% increase from $42.9 million in Q1 2025, driven by growth across all three reportable operating segments.
Gross Profit $2.8 million in Q1 2026, an improvement of nearly $8 million from a gross loss of $5.1 million in Q1 2025.
Operating Loss $6.3 million in Q1 2026, a 60% improvement from $15.6 million in Q1 2025.
Net Loss $21.7 million in Q1 2026, an improvement from $24.5 million in Q1 2025.
Production Tax Credits $4 million of operating income in Q1 2026, with $1.4 million from Dairy RNG and $2.6 million from California Ethanol, due to Section 45Z eligibility established in Q4 2025.
Adjusted EBITDA Negative $1.3 million in Q1 2026, reflecting typical winter seasonality.
Cash and Cash Equivalents $4.8 million at the end of Q1 2026, comparable to year-end 2025.
Capital Investments $6.5 million in carbon intensity reduction and Dairy Digester construction during Q1 2026.
Dairy RNG Sales 110,000 MMBtus sold in Q1 2026, a 55% increase over Q1 2025.
India Biodiesel Revenue $10.5 million in Q1 2026, rebounding due to the resumption of oil marketing company shipments under new contracts.
California Air Resources Board approval of 7 new low-carbon fuel standard pathways: Approval for renewable natural gas business with an average carbon intensity score of negative 380, compared to a negative 150 default. This approval has been providing additional revenue since Q3 2025.
Dairy Biogas pretreatment skids: Initial deliveries received in April under a $27 million fabrication contract.
Mechanical vapor compression project at Keyes ethanol plant: Major equipment for the $40 million project has arrived, and construction has begun. Expected to displace 80% of fossil natural gas consumption and add $32 million in annual cash flow.
India biodiesel revenue: Revenue rebounded to $10.5 million in Q1 due to resumption of oil marketing company shipments under new contracts. Supports planned IPO of India subsidiary, Universal Biofuels Private Limited.
Revenue growth: Revenue grew 27% year-over-year to $54.6 million in Q1 2026, with all three operating segments contributing.
Gross profit improvement: Gross profit improved by nearly $8 million year-over-year, reaching $2.8 million in Q1 2026.
Operating loss reduction: Operating loss improved by approximately 60%, reducing to $6.3 million compared to $15.6 million in Q1 2025.
Dairy RNG production: Sold 110,000 MMBtus in Q1, a 55% increase year-over-year. Construction and equipment delivery for 15 additional digesters are underway.
India IPO: Planned IPO of Universal Biofuels Private Limited, with legal, accounting, and IPO advisers retained.
Refinancing of existing debt: Focus on refinancing existing debt into long-term financing in 2026.
Adjusted EBITDA: The company reported a negative Adjusted EBITDA of $1.3 million, reflecting challenges related to typical winter seasonality and operational performance.
Operating Loss: Despite improvements, the company still reported an operating loss of $6.3 million, indicating ongoing financial challenges.
Net Loss: The company experienced a net loss of $21.7 million, which, although improved from the prior year, highlights continued financial strain.
Capital Investments: Significant capital investments of $6.5 million in carbon intensity reduction and Dairy Digester construction could strain cash flow, especially with cash and cash equivalents at $4.8 million.
Debt Refinancing: The company plans to refinance existing debt into long-term financing, which could pose risks if market conditions or credit availability deteriorate.
India IPO: The planned IPO of the India subsidiary introduces execution risks, including regulatory approvals, market conditions, and operational readiness.
LCFS Pathways Approval: While LCFS pathways approvals are beneficial, delays in the approval of six additional biogas digester pathways could impact revenue growth.
Ethanol Plant Project: The $40 million mechanical vapor compression project at the Keyes ethanol plant is under construction, and any delays or cost overruns could impact financial performance.
Scaling Production: The company plans to scale production in 2026, focusing on increasing the output of renewable fuels and dairy RNG.
Monetizing Renewable Fuels Platform: The company aims to monetize the stacked credit value of its renewable fuels platform, leveraging LCFS and 45Z credits.
India IPO: The company is preparing for the initial public offering of its India subsidiary, Universal Biofuels Private Limited, with legal, accounting, and IPO advisers already retained.
Debt Refinancing: The company plans to refinance existing debt into long-term financing during 2026.
Keyes Ethanol Plant MBR Project: The MBR project at the Keyes ethanol plant is on track for completion later in 2026, expected to add approximately $32 million in annual cash flow from operations by reducing carbon intensity and saving on natural gas costs.
LCFS Credit Prices: The company anticipates rising LCFS credit prices due to continued quarterly credit deficits, which will positively impact revenues.
45Z CF GRE Model Update: The company is tracking the publication of the updated 45Z CF GRE model by the Department of Energy, which is expected to significantly increase revenues and margins.
The selected topic was not discussed during the call.
The earnings call reveals strong growth in Dairy RNG and India Biodiesel sales, with optimistic guidance for the India biodiesel operations. Despite a negative EBITDA due to seasonality, the company is making significant capital investments. The Q&A highlights potential high revenue from the RD and SAF project and positive market trends for LCFS prices. Financing challenges remain, but the overall sentiment is positive, with expectations of improved margins and strategic expansions. The absence of market cap data limits precise prediction, but the overall sentiment suggests a positive stock price movement.
The earnings call indicates improvements in financial metrics, with reduced losses and increased income in key segments. The strategic focus on expanding RNG, ethanol, and biodiesel production, supported by government incentives, suggests growth potential. The Q&A further highlights positive EBITDA expectations and significant investments in infrastructure. Although there is some uncertainty regarding specific guidance and timelines, the overall sentiment is optimistic, with anticipated revenue increases from tax credits and market expansion. This positions the stock for a positive reaction over the next two weeks.
The earnings call summary and Q&A reveal mixed signals. While there are positive developments in debt repayment and product launches, there are also concerns about competition, churn, and lack of specific guidance on key issues. The financial performance shows a slight decline in free cash flow and capital expenditures. Overall, these factors balance out to a neutral sentiment.
The earnings call summary highlights multiple positive developments such as increased RNG production, ethanol plant upgrades, and biodiesel expansion, which are expected to enhance revenue and cash flow. The Q&A section reveals strong leasing spreads and NOI growth, with positive analyst sentiment. The strategic plan indicates optimistic guidance with new projects and regulatory support. Despite some uncertainties, the overall sentiment is positive due to promising financial metrics, expansion plans, and regulatory tailwinds, suggesting a likely stock price increase in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.